{"nct_id":"NCT02116660","title":"Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)","status":"TERMINATED","status_verified_date":"2019-04","start_date":"2014-09-03","start_date_type":"ACTUAL","primary_completion_date":"2017-07-10","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}